Related Experiment Video
Updated: Jan 12, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Drug safety: The roles of big data and clinical experience
1Chief Scientific Officer, Data Based Medicine, UNITED KINGDOM.
Abstract:
Following the pharmacovigilance crises of 2004 involving the use of Vioxx and antidepressants in minors, medicine regulators turned to big data, also called real-world evidence, to support their efforts to establish the safety of treatment protocols. In many areas of drug development, big data can clearly play a part; but to date, it has not helped resolve safety issues. Developments in artificial intelligence may help clarify the respective roles of big data and clinical expertise in pharmacovigilance in surprising ways.
More Related Videos
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Preclinical Development: Overview
Drug Regulation